Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisatracurium versus hyaluronidase added to levobupivacaine for single-injection peribulbar block in cataract surgery
PACTR201606001658235Completed
- Sponsor
- Faculty of Medicine, Tanta University
- Start
- Jan 2015
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of cisatracurium, hyaluronidase and levobupivacaine in cataract (2 arms), sponsored by Faculty of Medicine, Tanta University. Primary endpoint: Appearance of T sign. Started Jan 2015; status: completed.
02
Drugs
cisatracuriumhyaluronidaselevobupivacaine
03
Conditions
cataract
Beyond the preview
Go deeper on PACTR201606001658235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201606001658235.